Security key
68235C107
Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q2 2020 13F Holders as of 30 Jun 2020
- Security type / class
- Equity / Common Shares, No Par Value
- Total 13F shares
- 32,913,612
- Total 13F value
- $62,907,536
- Share change
- +5,390,836
- SEC-reported price per share
- $1.91
- Number of holders
- 57
- Value change
- +$9,179,739
- Number of buys
- 40
- Number of sells
- 15
- Shares outstanding
- 28,495,649
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2020
Institutions
57
Top holders
10
OCX full security history
Ownership snapshot
Full 13F holder table
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BROADWOOD CAPITAL INC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
0/15
Latest evidence
31 Mar 2020
13F
Highest disclosed value: $33,482,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BROADWOOD CAPITAL INC has the largest disclosed position value at $33.48M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BROADWOOD CAPITAL INC's linked filing trail.
Disclosed position value
Top 5
BROADWOOD CAPITAL INC
$33.48M
PURA VIDA INVESTMENTS, LLC
$13.67M
EMERALD MUTUAL FUND ADVISERS TRUST
$4.99M
BlackRock Finance, Inc.
$3.84M
VANGUARD GROUP INC
$3.48M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
Company
|
—
denominator unverified
|
$33,482,000
13,666,204 shares
|
— | 31 Mar 2020 |
| PURA VIDA INVESTMENTS, LLC |
13F
Company
|
—
denominator unverified
|
$13,667,000
5,578,283 shares
|
— | 31 Mar 2020 |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
Company
|
—
denominator unverified
|
$4,988,000
2,035,891 shares
|
— | 31 Mar 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$3,835,000
1,565,566 shares
|
— | 31 Mar 2020 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$3,484,000
1,422,052 shares
|
— | 31 Mar 2020 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$1,051,000
428,858 shares
|
— | 31 Mar 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
57
Shares
32,913,612
Rows available
57
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
52
Q2 2020 holders
57
Holder diff
5
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q2 2020 value | Value change | Value Chg % |
|---|